Cargando…
Challenges and opportunities for improving access to approved neonatal drugs and devices
Neonatal drug and device development has lagged behind other patient populations. Oftentimes, providers are using drugs and devices without adequate study of safety and efficacy. Neonates deserve dedicated drug and device development programs, which will require novel approaches and unique collabora...
Autores principales: | Lewis, Tamorah, Wade, Kelly C., Davis, Jonathan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819193/ https://www.ncbi.nlm.nih.gov/pubmed/35132149 http://dx.doi.org/10.1038/s41372-021-01304-2 |
Ejemplares similares
-
Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities
por: Dinh, Jean, et al.
Publicado: (2023) -
Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data
por: Lewis, Tamorah, et al.
Publicado: (2021) -
Challenges and opportunities in 2D heterostructures for electronic and optoelectronic devices
por: Chakraborty, Suman Kumar, et al.
Publicado: (2022) -
Tissue Chips in Space—Challenges and Opportunities
por: Yeung, Catherine K., et al.
Publicado: (2019) -
Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement
por: Delgado, Maria Fernanda, et al.
Publicado: (2019)